These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001331-36 A randomized phase III study of follow up with or without adjuvant Gefitinib (IressaTM) following chemotherapy in patients with advanced non-small cell lung cancer 2009-12-02 due-trials
Completed, but no date, and reported results 2004-004158-23 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON THE USE OF ACETYL-L-CARNITINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) bad-data
Reported results 2004-004525-99 A randomized, prospective, double-blind study to evaluate the effects on lipid profile of combined Ezetimibe and Simvastatin therapy as compared to Simvastatin alone in people with type 2 diabetes 2007-06-21 due-trials
Completed, but no date, and reported results 2005-004598-20 Clinical study of the association between n-3 PUFA and statin effects on inflammation and lipids. bad-data
Reported results 2005-005552-41 Effect of long-acting somatostatin on disease progression in nephropathy due to autosomal dominant polycystic disease a long-term three year follow-up study 2012-01-26 due-trials
Reported results 2006-003427-37 Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and safety 2009-07-24 due-trials
Reported results 2006-005604-14 A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy for k... 2017-11-29 due-trials
Reported results 2006-005951-14 A prospective, randomised, open-label blinded end point (PROBE) trial to evaluate, whether, at comparable blood pressure control, combined therapy with the ACE inhibitor benazepril and the angiotensin... 2016-04-01 due-trials
Reported results 2006-005954-62 A prospective, randomized, open label blinded end point probe trial to evaluate whether, at comparable blood pressure control, combined therapy with the ACE inhibitor Benazepril and the angiotensin ... 2018-06-28 due-trials
Ongoing, reported early 2007-000278-22 GiSAS trial aripiprazole, olanzapine and haloperidol in the long term treatment of schizophrenia. not-yet-due
Other 2007-004917-33 A Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma not-yet-due
Reported results Terminated 2007-005047-21 Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Disease and severe renal insufficiency 2012-07-16 due-trials
Reported results 2007-005925-31 A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF 6-MONTH ACETYLCARNITINE THERAPY ON ARTERIAL BLOOD PRESSURE, LIPID AND METABOLIC PROFILE, AND KIDNEY FUNCTION... 2012-03-26 due-trials
Reported results 2008-000822-38 A PROSPECTIVE, RANDOMIZED, OPEN LABEL BLINDED END POINT (PROBE), CROSS-OVER STUDY TO COMPARE THE EFFECTS OF TELMISARTAN AND LOSARTAN ON METABOLIC PROFILE OF RENAL TRANSPLANT PATIENTS Studio prospet... 2013-03-08 due-trials
Reported results 2008-003529-17 A PROSPECTIVE, RANDOMIZED, OPEN LABEL, BLINDED END-POINT (PROBE) TRIAL TO EVALUATE WHETHER, AT COMPARABLE BLOOD PRESSURE CONTROL, ACE INHIBITOR THERAPY MORE EFFECTIVELY THAN NON RAS INHIBITOR THERAPY ... 2016-04-27 due-trials
Reported results 2008-006380-36 A PROSPECTIVE, PILOT, CROSS-OVER STUDY TO ASSESS THE EFFICACY OF PARICALCITOL IN REDUCING PARATHYROID HORMONE LEVELS AND AMELIORATING MARKERS OF BONE REMODELLING IN RENAL TRANSPLANT RECIPIENTS WITH SE... 2012-07-23 due-trials
Reported results 2008-006750-17 A prospective, sequential study to assess the efficacy of rituximab therapy in maintaining remission of nephrotic syndrome after steroid and immunosuppressive therapy withdrawal in patients with stero... 2012-07-16 due-trials
Reported results 2009-011116-38 Efficacy of nebulised beclometasone versus placebo in preventing viral wheezing in pre-school children 2012-10-02 due-trials
Reported results Terminated 2009-012376-27 EFFECTS OF LONG-ACTING SOMATOSTATIN ON DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND MODERATE/SEVERE RENAL INSUFFICIENCY(ALADIN II STUDY) 2010-12-01 due-trials
Completed, but no date, and reported results Terminated 2009-013340-36 PREVENTION OF REPERFUSION INJURY IN HUMAN LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS BY TARGETING IL-8 ACTIVITY bad-data
Ongoing, reported early 2009-016017-24 A PHASE II RANDOMIZED NON COMPARATIVE STUDY ON THE ACTIVITY OF TRABECTEDIN OR GEMCITABINE + DOCETAXEL IN METASTATIC OR LOCALLY RELAPSED UTERINE LEIOMYOSARCOMA PRETREATED WITH CONVENTIONAL CHEMOTHER... not-yet-due
Completed, but no date 2010-019126-13 A PILOT, EXPLORATIVE STUDY TO IDENTIFY CONTRAST-ENHANCED ULTRASOUND (CE-US) PATTERNS THAT CHARACTERIZE ACUTE ALLOGRAFT REJECTION AND OTHER CAUSES OF ACUTE ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT REC... bad-data
Completed, but no date, and reported results 2010-021017-23 RCT comparing the analgesic efficacy of 4 therapeutic strategies based on 4 different major opioids (fentanyl, oxycodone, buprenorphine vs morphine) in cancer patients with moderate/severe pain, at th... bad-data
Reported results Terminated 2010-021052-25 ITACA-S 2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach): comparison of the efficacy of a peri-operative versus a post-operative chemotherapy treatment in patients wi... 2013-12-31 due-trials
Completed, but no date Terminated 2010-022021-15 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III, SUPERIORITY TRIAL TO ASSESS THE EFFICACY AND SAFETY OF ACETYL-L-CARNITINE IN COMBINATION WITH A C... bad-data
Ongoing 2010-022233-28 Fatal familial insomnia: preventive treatment with doxycycline of at risk individuals Insonnia Fatale Familiare: trattamento preventivo con doxiciclina in soggetti a rischio not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022949-17 A Phase III international, randomized study with Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with ovarian cancer progressing within 6-12 months of la... 2020-12-17 bad-data
Reported results Terminated 2010-024431-17 A PILOT STUDY TO EVALUATE THE INCIDENCE OF HYPONATREMIA IN A MEDICAL-SURGICAL HOSPITAL AND TO EXPLORE THE EFFICACY AND SAFETY OF TOLVAPTAN IN THE CLINICAL PRACTICE STUDIO PILOTA PER VALUTARE L'IN... 2012-07-26 due-trials
Reported results 2011-000138-12 A prospective, randomized, double-blind, placebo controlled clinical trial to assess the effects of long-acting somatostatin (Octreotide LAR)therapy on disease progression in patients with Autosomal D... 2017-10-18 due-trials
Reported results Terminated 2011-000785-35 A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENTS (... 2012-03-21 due-trials
Reported results 2011-001713-14 A PROSPECTIVE, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE ANTIPROTEINURIC EFFECT OF SELECTIVE VITAMIN D RECEPTOR ACTIVATION BY PARICALCITOL IN TYPE 2 DIABETES PATIENT... 2015-05-29 due-trials
Reported results 2011-002876-18 CYCLosporinE A in reperfused acute myocardial infarction (CYCLE-Trial) Ciclosporina A nell'infarto miocardico acuto riperfuso (studio CYCLE) 2014-11-17 due-trials
Reported results 2011-006330-16 ATREUS TRIAL A PHASE II STUDY ON THE ACTIVITY OF TRABECTEDIN IN PRETREATED EPITHELIOID OR BIPHASIC/SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA (MPM) STUDIO DI FASE II SULL'ATTIVITA' DELLA TRABECTE... 2019-12-09 due-trials
Completed, but no date, and reported results 2012-003618-15 Multicenter, randomized, non-comparative, open-label phase II trial on the efficacy of Ortataxel and Fotemustine in recurrent glioblastoma Studio clinico multicentrico, italiano, randomizzato, non-... bad-data
Reported results 2012-003866-42 Multicenter, randomized, non-comparative, open-label phase II trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in adult women with platin... 2018-03-15 due-trials
Reported results 2012-005416-26 A Prospective, Randomized, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess The Renal and Humoral Effects of Sevelamer Carbonate in Patients with Chronic Kidney Disease and Residual Proteinuri... 2015-09-21 due-trials
Reported results 2013-003826-10 EVALUATING THE MORPHOFUNCTIONAL EFFECTS OF ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: A PILOT, SINGLE ARM STUDY IN TEN PATIENTS WITH PERSISTENT HEAVY PROTEINURIA TE... 2017-12-19 due-trials
Completed, but no date, and reported results 2014-002508-26 Outcome-related factors in patients with metastatic renal cell carcinoma treated with everolimus after failure of a first-line treatment with VEGF inhibitor Fattori associati all’esito in pazienti ... bad-data
Reported results 2014-004194-16 A multicenter, single-arm, phase II study to evaluate the activity of pre-operative zoledronate in triple negative breast cancer patients, according to p53 level 2018-06-08 due-trials
Reported results Terminated 2014-004261-24 AN OPEN-LABEL PHASE 2 STUDY TO ASSESS THE EFFECT OF C5AR ANTAGONIST THERAPY BY CCX168 ORAL ADMINISTRATION ON EX VIVO THROMBUS FORMATION AND DISEASE ACTIVITY IN ESRD PATIENTS WITH ATYPICAL HEMOLYTIC U... 2017-02-24 due-trials
Completed, but no date, and reported results Terminated 2015-003278-34 A RANDOMIZED, CROSS-OVER, BIOEQUIVALENCE STUDY OF EFAVIRENZ TABLETS 600 mg OF MYLAN SpA AND SUSTIVA® (EFAVIRENZ) TABLETS 600 mg OF BRISTOL MYERS SQUIBB AT STEADY STATE IN PATIENTS WITH HIV-1 STUDIO... bad-data
Completed, but no date, and reported results 2016-000617-67 A phase II study to investigate the activity and safety of anti-PD-L1 antibody (Durvalumab) In ADvancEd pretreated malignant pleural Mesothelioma - DIADEM Study A phase II study to investigate the ... bad-data
Exempt 2016-000661-23 NOVEL STROMAL CELL THERAPY FOR DIABETIC KIDNEY DISEASE (NEPHSTROM Study) not-yet-due
Reported results Terminated 2016-001864-12 An international, multicenter, phase II, randomized, parallel-arm trial investigating the role of two different metronomic chemotherapy regimens in locally advanced or metastatic triple negative breas... 2018-07-23 due-trials
Ongoing, reported early 2016-002382-62 The effects of RNS60 on ALS biomarkers L'effetto del farmaco RNS60 sui biomarcatori della SLA not-yet-due
Completed, but no date, and reported results 2016-003964-38 The BAROCCO study (Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib): an Italian multicenter randomized phase II study of weekly paclitaxel vs. Cediranib-Olaparib with continuous sch... bad-data
Ongoing 2016-005112-17 Multicenter, randomized, phase II study of neoadjuvant chemotherapy associated or not with zoledronate and atorvastatin in triple negative breast cancers - YAPPETIZER Study Studio multicentrico, ra... not-yet-due
Reported results 2017-003595-30 Treat_CCM Clinical Trial. A multicenter randomized clinical trial on Propranolol in Cerebral Cavernous Malformation Studio multicentrico, randomizzato sul propranololo nella Malformazione Cavernosa... 2021-12-31 due-trials
Completed, but no date, and reported results 2017-004701-40 A PILOT, PHASE II STUDY WITH A PROSPECTIVE, RANDOMIZED, CROSS-OVER, PLACEBO-CONTROLLED, DOUBLE-BLIND DESIGN TO ASSESS THE SHORT-TERM EFFECTS OF TOLVAPTAN PLUS PLACEBO VS TOLVAPTAN PLUS OCTREOTIDE LAR... bad-data
Ongoing 2018-000781-10 EFFICACY AND TOLERABILITY OF LOW VS. STANDARD DAILY DOSES OF ANTIEPILEPTIC DRUGS IN NEWLY DIAGNOSED, PREVIOUSLY UNTREATED EPILEPSY (STANDLOW). A MULTICENTER, RANDOMIZED, SINGLE-BLIND, PARALLEL GROUP T... not-yet-due
Completed, but no date, and reported results Terminated 2018-001057-26 Management of the patient with heart failure and diabetes: may insulin be a problem? A pilot randomized clinical study (Insulin-HF). Trattamento del paziente con insufficienza cardiaca e diabete: l... bad-data
Other 2018-001072-37 AtTEnd: Atezolizumab Trial in Endometrial cancer - Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recu... not-yet-due
Ongoing 2018-001856-36 A RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE THE ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER EBC ATRA TRIAL ... not-yet-due
Exempt 2018-003047-32 CardioPulmonary resuscitation with Argon (CPAr) trial Rianimazione CardioPolmonare con Argon – Studio CPAr not-yet-due
Ongoing 2018-003736-77 A MULTICENTER, OPEN-LABEL PHASE II TRIAL OF A NEW CUSTOMIZED DOSING (RATIONAL ADJUSTMENT OF DOSE TO REDUCE ADVERSE REACTIONS “RADAR” DOSING) OF NIRAPARIB AS MAINTENANCE THERAPY IN PLATINUM SENSITIVE O... not-yet-due
Reported results Terminated 2018-004382-13 A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF CEMDISIRAN (ALN-CC5) FOLLOWING WITHDRAWAL OF CHRONIC ECULIZUMAB THERAPY IN PATIENTS WITH ATYPICA... 2020-11-05 due-trials
Ongoing 2019-004025-24 BRIDGE trial: Phase II trial of durvalumaB and chemotheRapy Induction followed by Durvalumab and radiotherapy in larGe volumE stage III NSCLC Essai BRIDGE : Essai de phase II sur le Durvalumab et l... not-yet-due
Reported results Terminated 2019-004152-10 Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF Stud... 2021-09-03 due-trials
Completed, but no date Terminated 2020-002773-10 A phase III prevention trial of canakinumab in subjects at high risk for lung cancer Studio di prevenzione di fase III in soggetti ad alto rischio per tumore al polmone che confronta un trattamento... bad-data
Ongoing 2020-005626-29 A phase II study on trabectedin in combination with PPARg agonist pioglitazone in patients with round cell myxoid liposarcomas or dedifferentiated G1 and G2 liposarcomas with stable disease after a mo... not-yet-due
Ongoing 2021-000726-10 Evaluating the short-term renal and systemic effects of Dapagliflozin in non-diabetic patients with stage IV CKD at risk of ESKD because of severe renal insufficiency and persistent proteinuria: A pro... not-yet-due
Ongoing 2021-000835-30 RESCUE THERAPY WITH THE HUMAN ANTI-CD38 ANTIBODY MOR202 (FELZARTAMAB) IN PATIENTS WITH MEMBRANOUS NEPHROPATHY WHO FAILED ANTI-CD20 TARGETED THERAPY: A PILOT, PROOF-OF-CONCEPT STUDY “Rescue therap... not-yet-due
Ongoing 2021-004864-81 Proposta di studio per valutare l’efficacia di Obinutuzumab, un anticorpo anti-CD20, in pazienti con nefropatia membranosa intolleranti, resistenti o dipendenti alla terapia con Rituximab (studio ORIO... not-yet-due